Floatz logo

Clarithromycin

Obesity, Morbid

Fatih Sultan Mehmet Training and Research HospitalSmall moleculePhase 4 / ApprovedDormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

42 Active assets in the Obesity, Morbid cohort.

Asset / SponsorPhaseRating
Liraglutide
University of Sao Paulo General Hospital
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Tanta University
Phase 4BB
Semaglutide
Zuyderland Medisch Centrum
Phase 4BB
CHLORHEXIDINE
University of Taubate
Phase 4BB
METAMIZOLE
Kirsehir Ahi Evran Universitesi
Phase 4BB

View all 50 →

Same molecule, other indications

Clarithromycin is also rated in:

Helicobacter Pylori InfectionDormant
BB
Indicative ·
69 / 100
View asset →
Epilepsy, GeneralizedDormant
B
Indicative ·
61 / 100
View asset →
Parkinson diseaseDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →